Loading…
A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study
Dementia has become a major public health concern due to its heavy disease burden. Mild cognitive impairment (MCI) is a transitional stage between healthy aging and dementia. Early identification of MCI is an essential step in dementia prevention. Based on machine learning (ML) methods, this study a...
Saved in:
Published in: | Journal of medical Internet research 2023-12, Vol.25 (2), p.e49147-e49147 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c394t-263fcc420170ec2a30eb3bc284c1a11bfb1725cde46cdd40661cedfd6bfdbd563 |
container_end_page | e49147 |
container_issue | 2 |
container_start_page | e49147 |
container_title | Journal of medical Internet research |
container_volume | 25 |
creator | Gu, Dongmei Lv, Xiaozhen Shi, Chuan Zhang, Tianhong Liu, Sha Fan, Zili Tu, Lihui Zhang, Ming Zhang, Nan Chen, Liming Wang, Zhijiang Wang, Jing Zhang, Ying Li, Huizi Wang, Luchun Zhu, Jiahui Zheng, Yaonan Wang, Huali Yu, Xin |
description | Dementia has become a major public health concern due to its heavy disease burden. Mild cognitive impairment (MCI) is a transitional stage between healthy aging and dementia. Early identification of MCI is an essential step in dementia prevention.
Based on machine learning (ML) methods, this study aimed to develop and validate a stable and scalable panel of cognitive tests for the early detection of MCI and dementia based on the Chinese Neuropsychological Consensus Battery (CNCB) in the Chinese Neuropsychological Normative Project (CN-NORM) cohort.
CN-NORM was a nationwide, multicenter study conducted in China with 871 participants, including an MCI group (n=327, 37.5%), a dementia group (n=186, 21.4%), and a cognitively normal (CN) group (n=358, 41.1%). We used the following 4 algorithms to select candidate variables: the F-score according to the SelectKBest method, the area under the curve (AUC) from logistic regression (LR), P values from the logit method, and backward stepwise elimination. Different models were constructed after considering the administration duration and complexity of combinations of various tests. Receiver operating characteristic curve and AUC metrics were used to evaluate the discriminative ability of the models via stratified sampling cross-validation and LR and support vector classification (SVC) algorithms. This model was further validated in the Alzheimer's Disease Neuroimaging Initiative phase 3 (ADNI-3) cohort (N=743), which included 416 (56%) CN subjects, 237 (31.9%) patients with MCI, and 90 (12.1%) patients with dementia.
Except for social cognition, all other domains in the CNCB differed between the MCI and CN groups (P |
doi_str_mv | 10.2196/49147 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c2ab99d9b3a7481a8475e74140bfab4e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A775115812</galeid><doaj_id>oai_doaj_org_article_c2ab99d9b3a7481a8475e74140bfab4e</doaj_id><sourcerecordid>A775115812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-263fcc420170ec2a30eb3bc284c1a11bfb1725cde46cdd40661cedfd6bfdbd563</originalsourceid><addsrcrecordid>eNpdks1uEzEUhUcIREvpKyBLCIlNwH-Z8bALaQuVUliksLWu7TvBkTNOPZ5KeRWetk5SCmLlv--co2udqjpn9ANnbf1Rtkw2z6pTJoWaKNWw5__sT6pXw7CmlNOCvaxOhKKipY08rX7PyDKDCUigd2RpIRwOF37lMwQyj5ttHHxG8g3HFG1c9T77eyS3OGTSxUQuIYUducAN9tlDcUiIve9X5DMM6EjsyQ3YX75HskBI-5dP5CY6DEVzjyFu98JD-E8I3kH2RbLMo9u9rl50EAY8f1zPqh9Xl7fzr5PF9y_X89liYkUr84TXorNWcsoaipaDoGiEsVxJy4Ax0xnW8Kl1KGvrnKR1zSy6ztWmc8ZNa3FWXR99XYS13ia_gbTTEbw-XMS00pCytwF1sTdt61ojoJGKgZLNFBvJJDUdGInF6_3Ra5vi3Vj-SG_8YDEE6DGOg-aqrRVjgtGCvv0PXccx9WVSzVvW1LytufpLraDk-76LOYHdm-pZ00wZmyrGC_XuSNkUhyFh9zQGo3pfD32oR-HePGaOZoPuifrTB_EAICa0DA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917629628</pqid></control><display><type>article</type><title>A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Library & Information Science Abstracts (LISA)</source><source>Publicly Available Content Database</source><source>Social Science Premium Collection</source><source>Library & Information Science Collection</source><source>PubMed Central</source><creator>Gu, Dongmei ; Lv, Xiaozhen ; Shi, Chuan ; Zhang, Tianhong ; Liu, Sha ; Fan, Zili ; Tu, Lihui ; Zhang, Ming ; Zhang, Nan ; Chen, Liming ; Wang, Zhijiang ; Wang, Jing ; Zhang, Ying ; Li, Huizi ; Wang, Luchun ; Zhu, Jiahui ; Zheng, Yaonan ; Wang, Huali ; Yu, Xin</creator><creatorcontrib>Gu, Dongmei ; Lv, Xiaozhen ; Shi, Chuan ; Zhang, Tianhong ; Liu, Sha ; Fan, Zili ; Tu, Lihui ; Zhang, Ming ; Zhang, Nan ; Chen, Liming ; Wang, Zhijiang ; Wang, Jing ; Zhang, Ying ; Li, Huizi ; Wang, Luchun ; Zhu, Jiahui ; Zheng, Yaonan ; Wang, Huali ; Yu, Xin ; Alzheimer's Disease Neuroimaging Initiative (ADNI)</creatorcontrib><description>Dementia has become a major public health concern due to its heavy disease burden. Mild cognitive impairment (MCI) is a transitional stage between healthy aging and dementia. Early identification of MCI is an essential step in dementia prevention.
Based on machine learning (ML) methods, this study aimed to develop and validate a stable and scalable panel of cognitive tests for the early detection of MCI and dementia based on the Chinese Neuropsychological Consensus Battery (CNCB) in the Chinese Neuropsychological Normative Project (CN-NORM) cohort.
CN-NORM was a nationwide, multicenter study conducted in China with 871 participants, including an MCI group (n=327, 37.5%), a dementia group (n=186, 21.4%), and a cognitively normal (CN) group (n=358, 41.1%). We used the following 4 algorithms to select candidate variables: the F-score according to the SelectKBest method, the area under the curve (AUC) from logistic regression (LR), P values from the logit method, and backward stepwise elimination. Different models were constructed after considering the administration duration and complexity of combinations of various tests. Receiver operating characteristic curve and AUC metrics were used to evaluate the discriminative ability of the models via stratified sampling cross-validation and LR and support vector classification (SVC) algorithms. This model was further validated in the Alzheimer's Disease Neuroimaging Initiative phase 3 (ADNI-3) cohort (N=743), which included 416 (56%) CN subjects, 237 (31.9%) patients with MCI, and 90 (12.1%) patients with dementia.
Except for social cognition, all other domains in the CNCB differed between the MCI and CN groups (P<.008). In feature selection results regarding discrimination between the MCI and CN groups, the Hopkins Verbal Learning Test-5 minutes Recall had the best performance, with the highest mean AUC of up to 0.80 (SD 0.02) and an F-score of up to 258.70. The scalability of model 5 (Hopkins Verbal Learning Test-5 minutes Recall and Trail Making Test-B) was the lowest. Model 5 achieved a higher level of discrimination than the Hong Kong Brief Cognitive test score in distinguishing between the MCI and CN groups (P<.05). Model 5 also provided the highest sensitivity of up to 0.82 (range 0.72-0.92) and 0.83 (range 0.75-0.91) according to LR and SVC, respectively. This model yielded a similar robust discriminative performance in the ADNI-3 cohort regarding differentiation between the MCI and CN groups, with a mean AUC of up to 0.81 (SD 0) according to both LR and SVC algorithms.
We developed a stable and scalable composite neurocognitive test based on ML that could differentiate not only between patients with MCI and controls but also between patients with different stages of cognitive impairment. This composite neurocognitive test is a feasible and practical digital biomarker that can potentially be used in large-scale cognitive screening and intervention studies.</description><identifier>ISSN: 1438-8871</identifier><identifier>ISSN: 1439-4456</identifier><identifier>EISSN: 1438-8871</identifier><identifier>DOI: 10.2196/49147</identifier><identifier>PMID: 38039074</identifier><language>eng</language><publisher>Canada: Journal of Medical Internet Research</publisher><subject>Aging ; Algorithms ; Alzheimer Disease - diagnosis ; Alzheimer's disease ; Biological markers ; Biomarkers ; Candidates ; Clinical assessment ; Cognitive ability ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - psychology ; Cognitive impairment ; Dementia ; Differentiation ; Discrimination ; Education ; Elimination ; Feature selection ; Humans ; Machine Learning ; Medical screening ; Medical tests ; Mental disorders ; Mental Status and Dementia Tests ; Missing data ; Multicenter studies ; Multimedia ; Neurocognition ; Neuroimaging ; Neuropsychological Tests ; Neuropsychology ; Older people ; Population ; Primary care ; Public health ; Social cognition ; Standard scores ; Tests ; Validation studies</subject><ispartof>Journal of medical Internet research, 2023-12, Vol.25 (2), p.e49147-e49147</ispartof><rights>Dongmei Gu, Xiaozhen Lv, Chuan Shi, Tianhong Zhang, Sha Liu, Zili Fan, Lihui Tu, Ming Zhang, Nan Zhang, Liming Chen, Zhijiang Wang, Jing Wang, Ying Zhang, Huizi Li, Luchun Wang, Jiahui Zhu, Yaonan Zheng, Huali Wang, Xin Yu, Alzheimer's Disease Neuroimaging Initiative (ADNI). Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 01.12.2023.</rights><rights>COPYRIGHT 2023 Journal of Medical Internet Research</rights><rights>2023. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c394t-263fcc420170ec2a30eb3bc284c1a11bfb1725cde46cdd40661cedfd6bfdbd563</cites><orcidid>0000-0003-1136-8006 ; 0000-0002-9752-3881 ; 0000-0002-9675-5322 ; 0000-0003-0312-9857 ; 0009-0003-2157-8768 ; 0000-0002-2627-1189 ; 0000-0002-5379-7119 ; 0009-0003-1159-5409 ; 0000-0003-3983-4937 ; 0000-0002-4640-1577 ; 0000-0001-6301-6817 ; 0000-0002-4938-6536 ; 0000-0003-4045-419X ; 0000-0002-8282-4964 ; 0000-0003-1041-8569 ; 0000-0002-3213-6493 ; 0000-0001-8921-095X ; 0000-0003-0934-3168 ; 0000-0002-6710-8126</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2917629628/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2917629628?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,12825,21360,21373,25731,27282,27901,27902,30976,33588,33589,33883,33884,34112,36989,36990,43709,43868,44566,74192,74379,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38039074$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gu, Dongmei</creatorcontrib><creatorcontrib>Lv, Xiaozhen</creatorcontrib><creatorcontrib>Shi, Chuan</creatorcontrib><creatorcontrib>Zhang, Tianhong</creatorcontrib><creatorcontrib>Liu, Sha</creatorcontrib><creatorcontrib>Fan, Zili</creatorcontrib><creatorcontrib>Tu, Lihui</creatorcontrib><creatorcontrib>Zhang, Ming</creatorcontrib><creatorcontrib>Zhang, Nan</creatorcontrib><creatorcontrib>Chen, Liming</creatorcontrib><creatorcontrib>Wang, Zhijiang</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Zhang, Ying</creatorcontrib><creatorcontrib>Li, Huizi</creatorcontrib><creatorcontrib>Wang, Luchun</creatorcontrib><creatorcontrib>Zhu, Jiahui</creatorcontrib><creatorcontrib>Zheng, Yaonan</creatorcontrib><creatorcontrib>Wang, Huali</creatorcontrib><creatorcontrib>Yu, Xin</creatorcontrib><creatorcontrib>Alzheimer's Disease Neuroimaging Initiative (ADNI)</creatorcontrib><title>A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study</title><title>Journal of medical Internet research</title><addtitle>J Med Internet Res</addtitle><description>Dementia has become a major public health concern due to its heavy disease burden. Mild cognitive impairment (MCI) is a transitional stage between healthy aging and dementia. Early identification of MCI is an essential step in dementia prevention.
Based on machine learning (ML) methods, this study aimed to develop and validate a stable and scalable panel of cognitive tests for the early detection of MCI and dementia based on the Chinese Neuropsychological Consensus Battery (CNCB) in the Chinese Neuropsychological Normative Project (CN-NORM) cohort.
CN-NORM was a nationwide, multicenter study conducted in China with 871 participants, including an MCI group (n=327, 37.5%), a dementia group (n=186, 21.4%), and a cognitively normal (CN) group (n=358, 41.1%). We used the following 4 algorithms to select candidate variables: the F-score according to the SelectKBest method, the area under the curve (AUC) from logistic regression (LR), P values from the logit method, and backward stepwise elimination. Different models were constructed after considering the administration duration and complexity of combinations of various tests. Receiver operating characteristic curve and AUC metrics were used to evaluate the discriminative ability of the models via stratified sampling cross-validation and LR and support vector classification (SVC) algorithms. This model was further validated in the Alzheimer's Disease Neuroimaging Initiative phase 3 (ADNI-3) cohort (N=743), which included 416 (56%) CN subjects, 237 (31.9%) patients with MCI, and 90 (12.1%) patients with dementia.
Except for social cognition, all other domains in the CNCB differed between the MCI and CN groups (P<.008). In feature selection results regarding discrimination between the MCI and CN groups, the Hopkins Verbal Learning Test-5 minutes Recall had the best performance, with the highest mean AUC of up to 0.80 (SD 0.02) and an F-score of up to 258.70. The scalability of model 5 (Hopkins Verbal Learning Test-5 minutes Recall and Trail Making Test-B) was the lowest. Model 5 achieved a higher level of discrimination than the Hong Kong Brief Cognitive test score in distinguishing between the MCI and CN groups (P<.05). Model 5 also provided the highest sensitivity of up to 0.82 (range 0.72-0.92) and 0.83 (range 0.75-0.91) according to LR and SVC, respectively. This model yielded a similar robust discriminative performance in the ADNI-3 cohort regarding differentiation between the MCI and CN groups, with a mean AUC of up to 0.81 (SD 0) according to both LR and SVC algorithms.
We developed a stable and scalable composite neurocognitive test based on ML that could differentiate not only between patients with MCI and controls but also between patients with different stages of cognitive impairment. This composite neurocognitive test is a feasible and practical digital biomarker that can potentially be used in large-scale cognitive screening and intervention studies.</description><subject>Aging</subject><subject>Algorithms</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer's disease</subject><subject>Biological markers</subject><subject>Biomarkers</subject><subject>Candidates</subject><subject>Clinical assessment</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - psychology</subject><subject>Cognitive impairment</subject><subject>Dementia</subject><subject>Differentiation</subject><subject>Discrimination</subject><subject>Education</subject><subject>Elimination</subject><subject>Feature selection</subject><subject>Humans</subject><subject>Machine Learning</subject><subject>Medical screening</subject><subject>Medical tests</subject><subject>Mental disorders</subject><subject>Mental Status and Dementia Tests</subject><subject>Missing data</subject><subject>Multicenter studies</subject><subject>Multimedia</subject><subject>Neurocognition</subject><subject>Neuroimaging</subject><subject>Neuropsychological Tests</subject><subject>Neuropsychology</subject><subject>Older people</subject><subject>Population</subject><subject>Primary care</subject><subject>Public health</subject><subject>Social cognition</subject><subject>Standard scores</subject><subject>Tests</subject><subject>Validation studies</subject><issn>1438-8871</issn><issn>1439-4456</issn><issn>1438-8871</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>ALSLI</sourceid><sourceid>CNYFK</sourceid><sourceid>F2A</sourceid><sourceid>M1O</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks1uEzEUhUcIREvpKyBLCIlNwH-Z8bALaQuVUliksLWu7TvBkTNOPZ5KeRWetk5SCmLlv--co2udqjpn9ANnbf1Rtkw2z6pTJoWaKNWw5__sT6pXw7CmlNOCvaxOhKKipY08rX7PyDKDCUigd2RpIRwOF37lMwQyj5ttHHxG8g3HFG1c9T77eyS3OGTSxUQuIYUducAN9tlDcUiIve9X5DMM6EjsyQ3YX75HskBI-5dP5CY6DEVzjyFu98JD-E8I3kH2RbLMo9u9rl50EAY8f1zPqh9Xl7fzr5PF9y_X89liYkUr84TXorNWcsoaipaDoGiEsVxJy4Ax0xnW8Kl1KGvrnKR1zSy6ztWmc8ZNa3FWXR99XYS13ia_gbTTEbw-XMS00pCytwF1sTdt61ojoJGKgZLNFBvJJDUdGInF6_3Ra5vi3Vj-SG_8YDEE6DGOg-aqrRVjgtGCvv0PXccx9WVSzVvW1LytufpLraDk-76LOYHdm-pZ00wZmyrGC_XuSNkUhyFh9zQGo3pfD32oR-HePGaOZoPuifrTB_EAICa0DA</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Gu, Dongmei</creator><creator>Lv, Xiaozhen</creator><creator>Shi, Chuan</creator><creator>Zhang, Tianhong</creator><creator>Liu, Sha</creator><creator>Fan, Zili</creator><creator>Tu, Lihui</creator><creator>Zhang, Ming</creator><creator>Zhang, Nan</creator><creator>Chen, Liming</creator><creator>Wang, Zhijiang</creator><creator>Wang, Jing</creator><creator>Zhang, Ying</creator><creator>Li, Huizi</creator><creator>Wang, Luchun</creator><creator>Zhu, Jiahui</creator><creator>Zheng, Yaonan</creator><creator>Wang, Huali</creator><creator>Yu, Xin</creator><general>Journal of Medical Internet Research</general><general>Gunther Eysenbach MD MPH, Associate Professor</general><general>JMIR Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QJ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CNYFK</scope><scope>DWQXO</scope><scope>E3H</scope><scope>F2A</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1O</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRQQA</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1136-8006</orcidid><orcidid>https://orcid.org/0000-0002-9752-3881</orcidid><orcidid>https://orcid.org/0000-0002-9675-5322</orcidid><orcidid>https://orcid.org/0000-0003-0312-9857</orcidid><orcidid>https://orcid.org/0009-0003-2157-8768</orcidid><orcidid>https://orcid.org/0000-0002-2627-1189</orcidid><orcidid>https://orcid.org/0000-0002-5379-7119</orcidid><orcidid>https://orcid.org/0009-0003-1159-5409</orcidid><orcidid>https://orcid.org/0000-0003-3983-4937</orcidid><orcidid>https://orcid.org/0000-0002-4640-1577</orcidid><orcidid>https://orcid.org/0000-0001-6301-6817</orcidid><orcidid>https://orcid.org/0000-0002-4938-6536</orcidid><orcidid>https://orcid.org/0000-0003-4045-419X</orcidid><orcidid>https://orcid.org/0000-0002-8282-4964</orcidid><orcidid>https://orcid.org/0000-0003-1041-8569</orcidid><orcidid>https://orcid.org/0000-0002-3213-6493</orcidid><orcidid>https://orcid.org/0000-0001-8921-095X</orcidid><orcidid>https://orcid.org/0000-0003-0934-3168</orcidid><orcidid>https://orcid.org/0000-0002-6710-8126</orcidid></search><sort><creationdate>20231201</creationdate><title>A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study</title><author>Gu, Dongmei ; Lv, Xiaozhen ; Shi, Chuan ; Zhang, Tianhong ; Liu, Sha ; Fan, Zili ; Tu, Lihui ; Zhang, Ming ; Zhang, Nan ; Chen, Liming ; Wang, Zhijiang ; Wang, Jing ; Zhang, Ying ; Li, Huizi ; Wang, Luchun ; Zhu, Jiahui ; Zheng, Yaonan ; Wang, Huali ; Yu, Xin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-263fcc420170ec2a30eb3bc284c1a11bfb1725cde46cdd40661cedfd6bfdbd563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aging</topic><topic>Algorithms</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer's disease</topic><topic>Biological markers</topic><topic>Biomarkers</topic><topic>Candidates</topic><topic>Clinical assessment</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - psychology</topic><topic>Cognitive impairment</topic><topic>Dementia</topic><topic>Differentiation</topic><topic>Discrimination</topic><topic>Education</topic><topic>Elimination</topic><topic>Feature selection</topic><topic>Humans</topic><topic>Machine Learning</topic><topic>Medical screening</topic><topic>Medical tests</topic><topic>Mental disorders</topic><topic>Mental Status and Dementia Tests</topic><topic>Missing data</topic><topic>Multicenter studies</topic><topic>Multimedia</topic><topic>Neurocognition</topic><topic>Neuroimaging</topic><topic>Neuropsychological Tests</topic><topic>Neuropsychology</topic><topic>Older people</topic><topic>Population</topic><topic>Primary care</topic><topic>Public health</topic><topic>Social cognition</topic><topic>Standard scores</topic><topic>Tests</topic><topic>Validation studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gu, Dongmei</creatorcontrib><creatorcontrib>Lv, Xiaozhen</creatorcontrib><creatorcontrib>Shi, Chuan</creatorcontrib><creatorcontrib>Zhang, Tianhong</creatorcontrib><creatorcontrib>Liu, Sha</creatorcontrib><creatorcontrib>Fan, Zili</creatorcontrib><creatorcontrib>Tu, Lihui</creatorcontrib><creatorcontrib>Zhang, Ming</creatorcontrib><creatorcontrib>Zhang, Nan</creatorcontrib><creatorcontrib>Chen, Liming</creatorcontrib><creatorcontrib>Wang, Zhijiang</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Zhang, Ying</creatorcontrib><creatorcontrib>Li, Huizi</creatorcontrib><creatorcontrib>Wang, Luchun</creatorcontrib><creatorcontrib>Zhu, Jiahui</creatorcontrib><creatorcontrib>Zheng, Yaonan</creatorcontrib><creatorcontrib>Wang, Huali</creatorcontrib><creatorcontrib>Yu, Xin</creatorcontrib><creatorcontrib>Alzheimer's Disease Neuroimaging Initiative (ADNI)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Library & Information Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Library & Information Sciences Abstracts (LISA)</collection><collection>Library & Information Science Abstracts (LISA)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Library Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Social Sciences</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of medical Internet research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gu, Dongmei</au><au>Lv, Xiaozhen</au><au>Shi, Chuan</au><au>Zhang, Tianhong</au><au>Liu, Sha</au><au>Fan, Zili</au><au>Tu, Lihui</au><au>Zhang, Ming</au><au>Zhang, Nan</au><au>Chen, Liming</au><au>Wang, Zhijiang</au><au>Wang, Jing</au><au>Zhang, Ying</au><au>Li, Huizi</au><au>Wang, Luchun</au><au>Zhu, Jiahui</au><au>Zheng, Yaonan</au><au>Wang, Huali</au><au>Yu, Xin</au><aucorp>Alzheimer's Disease Neuroimaging Initiative (ADNI)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study</atitle><jtitle>Journal of medical Internet research</jtitle><addtitle>J Med Internet Res</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>25</volume><issue>2</issue><spage>e49147</spage><epage>e49147</epage><pages>e49147-e49147</pages><issn>1438-8871</issn><issn>1439-4456</issn><eissn>1438-8871</eissn><abstract>Dementia has become a major public health concern due to its heavy disease burden. Mild cognitive impairment (MCI) is a transitional stage between healthy aging and dementia. Early identification of MCI is an essential step in dementia prevention.
Based on machine learning (ML) methods, this study aimed to develop and validate a stable and scalable panel of cognitive tests for the early detection of MCI and dementia based on the Chinese Neuropsychological Consensus Battery (CNCB) in the Chinese Neuropsychological Normative Project (CN-NORM) cohort.
CN-NORM was a nationwide, multicenter study conducted in China with 871 participants, including an MCI group (n=327, 37.5%), a dementia group (n=186, 21.4%), and a cognitively normal (CN) group (n=358, 41.1%). We used the following 4 algorithms to select candidate variables: the F-score according to the SelectKBest method, the area under the curve (AUC) from logistic regression (LR), P values from the logit method, and backward stepwise elimination. Different models were constructed after considering the administration duration and complexity of combinations of various tests. Receiver operating characteristic curve and AUC metrics were used to evaluate the discriminative ability of the models via stratified sampling cross-validation and LR and support vector classification (SVC) algorithms. This model was further validated in the Alzheimer's Disease Neuroimaging Initiative phase 3 (ADNI-3) cohort (N=743), which included 416 (56%) CN subjects, 237 (31.9%) patients with MCI, and 90 (12.1%) patients with dementia.
Except for social cognition, all other domains in the CNCB differed between the MCI and CN groups (P<.008). In feature selection results regarding discrimination between the MCI and CN groups, the Hopkins Verbal Learning Test-5 minutes Recall had the best performance, with the highest mean AUC of up to 0.80 (SD 0.02) and an F-score of up to 258.70. The scalability of model 5 (Hopkins Verbal Learning Test-5 minutes Recall and Trail Making Test-B) was the lowest. Model 5 achieved a higher level of discrimination than the Hong Kong Brief Cognitive test score in distinguishing between the MCI and CN groups (P<.05). Model 5 also provided the highest sensitivity of up to 0.82 (range 0.72-0.92) and 0.83 (range 0.75-0.91) according to LR and SVC, respectively. This model yielded a similar robust discriminative performance in the ADNI-3 cohort regarding differentiation between the MCI and CN groups, with a mean AUC of up to 0.81 (SD 0) according to both LR and SVC algorithms.
We developed a stable and scalable composite neurocognitive test based on ML that could differentiate not only between patients with MCI and controls but also between patients with different stages of cognitive impairment. This composite neurocognitive test is a feasible and practical digital biomarker that can potentially be used in large-scale cognitive screening and intervention studies.</abstract><cop>Canada</cop><pub>Journal of Medical Internet Research</pub><pmid>38039074</pmid><doi>10.2196/49147</doi><orcidid>https://orcid.org/0000-0003-1136-8006</orcidid><orcidid>https://orcid.org/0000-0002-9752-3881</orcidid><orcidid>https://orcid.org/0000-0002-9675-5322</orcidid><orcidid>https://orcid.org/0000-0003-0312-9857</orcidid><orcidid>https://orcid.org/0009-0003-2157-8768</orcidid><orcidid>https://orcid.org/0000-0002-2627-1189</orcidid><orcidid>https://orcid.org/0000-0002-5379-7119</orcidid><orcidid>https://orcid.org/0009-0003-1159-5409</orcidid><orcidid>https://orcid.org/0000-0003-3983-4937</orcidid><orcidid>https://orcid.org/0000-0002-4640-1577</orcidid><orcidid>https://orcid.org/0000-0001-6301-6817</orcidid><orcidid>https://orcid.org/0000-0002-4938-6536</orcidid><orcidid>https://orcid.org/0000-0003-4045-419X</orcidid><orcidid>https://orcid.org/0000-0002-8282-4964</orcidid><orcidid>https://orcid.org/0000-0003-1041-8569</orcidid><orcidid>https://orcid.org/0000-0002-3213-6493</orcidid><orcidid>https://orcid.org/0000-0001-8921-095X</orcidid><orcidid>https://orcid.org/0000-0003-0934-3168</orcidid><orcidid>https://orcid.org/0000-0002-6710-8126</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1438-8871 |
ispartof | Journal of medical Internet research, 2023-12, Vol.25 (2), p.e49147-e49147 |
issn | 1438-8871 1439-4456 1438-8871 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_c2ab99d9b3a7481a8475e74140bfab4e |
source | Applied Social Sciences Index & Abstracts (ASSIA); Library & Information Science Abstracts (LISA); Publicly Available Content Database; Social Science Premium Collection; Library & Information Science Collection; PubMed Central |
subjects | Aging Algorithms Alzheimer Disease - diagnosis Alzheimer's disease Biological markers Biomarkers Candidates Clinical assessment Cognitive ability Cognitive Dysfunction - diagnosis Cognitive Dysfunction - psychology Cognitive impairment Dementia Differentiation Discrimination Education Elimination Feature selection Humans Machine Learning Medical screening Medical tests Mental disorders Mental Status and Dementia Tests Missing data Multicenter studies Multimedia Neurocognition Neuroimaging Neuropsychological Tests Neuropsychology Older people Population Primary care Public health Social cognition Standard scores Tests Validation studies |
title | A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T22%3A32%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Stable%20and%20Scalable%20Digital%20Composite%20Neurocognitive%20Test%20for%20Early%20Dementia%20Screening%20Based%20on%20Machine%20Learning:%20Model%20Development%20and%20Validation%20Study&rft.jtitle=Journal%20of%20medical%20Internet%20research&rft.au=Gu,%20Dongmei&rft.aucorp=Alzheimer's%20Disease%20Neuroimaging%20Initiative%20(ADNI)&rft.date=2023-12-01&rft.volume=25&rft.issue=2&rft.spage=e49147&rft.epage=e49147&rft.pages=e49147-e49147&rft.issn=1438-8871&rft.eissn=1438-8871&rft_id=info:doi/10.2196/49147&rft_dat=%3Cgale_doaj_%3EA775115812%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c394t-263fcc420170ec2a30eb3bc284c1a11bfb1725cde46cdd40661cedfd6bfdbd563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2917629628&rft_id=info:pmid/38039074&rft_galeid=A775115812&rfr_iscdi=true |